Clinical Trial

Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment

Study acronym: IMPACT
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment to reduce their NPS, and to investigate the feasibility and effectiveness of the intervention.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-10-02 -> 2026-12-31 2026-05-19
minor Completion pushed: 2026-10-02 -> 2026-12-31 2026-05-19
Trial Details
NCT Number NCT07420426
Lead Sponsor The University of Hong Kong
Conditions Mild Cognitive Impairment (MCI)
Enrollment 160 participants
Start Date 2025-12-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18